Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes

Journal of Immunological Methods

Volumn 370, Issue 1-2, 2011, Pages 75-85

  Fofana, Ismael Ben F ^a   Colantonio, Arnaud D ^a   Reeves, R Keith ^a   Connole, Michelle A ^a   Gillis, Jacqueline M ^a   Hall, Laura R ^a   Sato, Shuji ^a   Audin, Craig R ^a   Evans, David T ^a   Shida, Hisatoshi ^b   Johnson, R Paul ^a   Johnson, Welkin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

B cells; Env; HIV; Neutralizing antibodies; Rhesus macaque; SIV

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OLIGOMER; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS IDENTIFICATION;

ANIMALS; B-LYMPHOCYTES; CELL LINE; FLOW CYTOMETRY; HUMANS; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79960071127     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.05.010     Document Type: Article

References (30)

1. Binley J.M., et al. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 2000, 74(2):627.
2. Browning J., et al. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(26):14637.
3. Cole K.S., et al. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology 2001, 290(1):59.
4. Doria-Rose N.A., et al. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J. Virol. 2009, 83(1):188.
5. Dykhuizen M., et al. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J. Gen. Virol. 1998, 79(Pt 10):2461.
6. Edinger A.L., et al. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J. Virol. 2000, 74(17):7922.
7. Farzan M., et al. Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J. Virol. 1998, 72(9):7620.
8. Gauduin M.C., et al. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV. J. Virol. 1998, 72(8):6315.
9. Gauduin M.C., et al. Characterization of SIV-specific CD4+ T-helper proliferative responses in macaques immunized with live-attenuated SIV. J. Med. Primatol. 1999, 28(4-5):233.
10. Gauduin M.C., et al. Immunization with live attenuated simian immunodeficiency virus induces strong type 1T helper responses and beta-chemokine production. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(24):14031.
11. Gauduin M.C., et al. Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection. J. Exp. Med. 2006, 203(12):2661.
12. Gray E.S., et al. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. J. Virol. 2009, 83(21):11265.
13. Hammonds J., et al. Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization. J. Virol. 2005, 79(23):14804.
14. Johnson W.E., et al. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J. Virol. 2003, 77(18):9993.
15. Keppler O.T., et al. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 2001, 75(17):8063.
16. Keppler O.T., et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 2002, 195(6):719.
17. Kuhrt D., et al. Evidence of early B-cell dysregulation in simian immunodeficiency virus infection: rapid depletion of naive and memory B-cell subsets with delayed reconstitution of the naive B-cell population. J. Virol. 2010, 84(5):2466-2476.
18. LaBranche C.C., et al. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol. 1995, 69(9):5217.
19. Li Y., et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 2007, 13(9):1032.
20. Mansfield K., et al. Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery. J. Virol. 2008, 82(8):4135.
21. Mattapallil J.J., Letvin N.L., Roederer M. T-cell dynamics during acute SIV infection. AIDS 2004, 18(1):13.
22. Okada H., et al. Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages. Retrovirology 2009, 6:43.
23. Robinson J.E., et al. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res. Hum. Retroviruses 1998, 14(14):1253.
24. Rosati M., et al. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J. Virol. 2005, 79(13):8480.
25. Sato S., Johnson W. Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS. Curr. HIV Res. 2007, 5(6):594.
26. Scheid J.F., et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458(7238):636.
27. Scheid J.F., et al. A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 2009, 343(2):65.
28. Steger K.K., et al. CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. J. Virol. 1998, 72(2):1600.
29. Yang X., et al. Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J. Virol. 2000, 74(10):4746.
30. Yang X., et al. Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 2000, 74(12):5716.